{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:17:35Z","timestamp":1793852255056,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T00:00:00Z","timestamp":1706054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The mechanistic target of rapamycin complex 1 (mTORC1) is a master regulator of cell growth, metabolism and autophagy. Multiple pathways modulate mTORC1 in response to nutrients. Here we describe that nucleus\u2013cytoplasmic shuttling of p300\/EP300 regulates mTORC1 activity in response to amino acid or glucose levels. Depletion of these nutrients causes cytoplasm-to-nucleus relocalization of p300 that decreases acetylation of the mTORC1 component raptor, thereby reducing mTORC1 activity and activating autophagy. This is mediated by AMP-activated protein kinase-dependent phosphorylation of p300 at serine 89. Nutrient addition to starved cells results in protein phosphatase 2A-dependent dephosphorylation of nuclear p300, enabling its CRM1-dependent export to the cytoplasm to mediate mTORC1 reactivation. p300 shuttling regulates mTORC1 in most cell types and occurs in response to altered nutrients in diverse mouse tissues. Interestingly, p300 cytoplasm\u2013nucleus shuttling is altered in cells from patients with Hutchinson\u2013Gilford progeria syndrome. p300 mislocalization by the disease-causing protein, progerin, activates mTORC1 and inhibits autophagy, phenotypes that are normalized by modulating p300 shuttling. These results reveal how nutrients regulate mTORC1, a cytoplasmic complex, by shuttling its positive regulator p300 in and out of the nucleus, and how this pathway is misregulated in Hutchinson\u2013Gilford progeria syndrome, causing mTORC1 hyperactivation and defective autophagy.<\/jats:p>","DOI":"10.1038\/s41556-023-01338-y","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T09:14:53Z","timestamp":1706087693000},"page":"235-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["p300 nucleocytoplasmic shuttling underlies mTORC1 hyperactivation in Hutchinson\u2013Gilford progeria syndrome"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3536-1952","authenticated-orcid":false,"given":"Sung Min","family":"Son","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia Y.","family":"Breusegem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2335-9361","authenticated-orcid":false,"given":"Delphine","family":"Larrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5002-5263","authenticated-orcid":false,"given":"David C.","family":"Rubinsztein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,24]]},"reference":[{"key":"1338_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"1338_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.tibs.2013.01.004","volume":"38","author":"JL Jewell","year":"2013","unstructured":"Jewell, J. L. & Guan, K. L. Nutrient signaling to mTOR and cell growth. Trends Biochem. Sci. 38, 233\u2013242 (2013).","journal-title":"Trends Biochem. Sci."},{"key":"1338_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrm3522","volume":"14","author":"JL Jewell","year":"2013","unstructured":"Jewell, J. L., Russell, R. C. & Guan, K. L. Amino acid signalling upstream of mTOR. Nat. Rev. Mol. Cell Biol. 14, 133\u2013139 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1338_CR4","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/ncb2763","volume":"15","author":"CC Dibble","year":"2013","unstructured":"Dibble, C. C. & Manning, B. D. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nat. Cell Biol. 15, 555\u2013564 (2013).","journal-title":"Nat. Cell Biol."},{"key":"1338_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 169, 361\u2013371 (2017).","journal-title":"Cell"},{"key":"1338_CR6","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"1338_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.aab2674","volume":"351","author":"RL Wolfson","year":"2016","unstructured":"Wolfson, R. L. et al. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351, 43\u201348 (2016).","journal-title":"Science"},{"key":"1338_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.cmet.2018.08.013","volume":"29","author":"SM Son","year":"2019","unstructured":"Son, S. M. et al. Leucine signals to mTORC1 via its metabolite acetyl-coenzyme A. Cell Metab. 29, 192\u2013201 e197 (2019).","journal-title":"Cell Metab."},{"key":"1338_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16886-2","volume":"11","author":"SM Son","year":"2020","unstructured":"Son, S. M. et al. Leucine regulates autophagy via acetylation of the mTORC1 component raptor. Nat. Commun. 11, 3148 (2020).","journal-title":"Nat. Commun."},{"key":"1338_CR10","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","volume":"584","author":"CH Jung","year":"2010","unstructured":"Jung, C. H., Ro, S. H., Cao, J., Otto, N. M. & Kim, D. H. mTOR regulation of autophagy. FEBS Lett. 584, 1287\u20131295 (2010).","journal-title":"FEBS Lett."},{"key":"1338_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nature01629","volume":"423","author":"M Eriksson","year":"2003","unstructured":"Eriksson, M. et al. Recurrent de novo point mutations in lamin A cause Hutchinson\u2013Gilford progeria syndrome. Nature 423, 293\u2013298 (2003).","journal-title":"Nature"},{"key":"1338_CR12","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1126\/science.1084125","volume":"300","author":"A De Sandre-Giovannoli","year":"2003","unstructured":"De Sandre-Giovannoli, A. et al. Lamin a truncation in Hutchinson\u2013Gilford progeria. Science 300, 2055 (2003).","journal-title":"Science"},{"key":"1338_CR13","doi-asserted-by":"publisher","first-page":"8963","DOI":"10.1073\/pnas.0402943101","volume":"101","author":"RD Goldman","year":"2004","unstructured":"Goldman, R. D. et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson\u2013Gilford progeria syndrome. Proc. Natl Acad. Sci. USA 101, 8963\u20138968 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1338_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.arr.2016.06.007","volume":"33","author":"S Gonzalo","year":"2017","unstructured":"Gonzalo, S., Kreienkamp, R. & Askjaer, P. Hutchinson\u2013Gilford progeria syndrome: a premature aging disease caused by LMNA gene mutations. Ageing Res. Rev. 33, 18\u201329 (2017).","journal-title":"Ageing Res. Rev."},{"key":"1338_CR15","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/j.cell.2016.05.017","volume":"165","author":"N Kubben","year":"2016","unstructured":"Kubben, N. et al. Repression of the antioxidant NRF2 pathway in premature aging. Cell 165, 1361\u20131374 (2016).","journal-title":"Cell"},{"key":"1338_CR16","doi-asserted-by":"publisher","first-page":"8703","DOI":"10.1073\/pnas.0602569103","volume":"103","author":"DK Shumaker","year":"2006","unstructured":"Shumaker, D. K. et al. Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging. Proc. Natl Acad. Sci. USA 103, 8703\u20138708 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1338_CR17","doi-asserted-by":"publisher","first-page":"89ra58","DOI":"10.1126\/scitranslmed.3002346","volume":"3","author":"K Cao","year":"2011","unstructured":"Cao, K. et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson\u2013Gilford progeria syndrome cells. Sci. Transl. Med. 3, 89ra58 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1338_CR18","doi-asserted-by":"publisher","first-page":"e13457","DOI":"10.1111\/acel.13457","volume":"20","author":"WA Cabral","year":"2021","unstructured":"Cabral, W. A. et al. Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson\u2013Gilford progeria syndrome. Aging Cell 20, e13457 (2021).","journal-title":"Aging Cell"},{"key":"1338_CR19","doi-asserted-by":"publisher","first-page":"8314","DOI":"10.1021\/acs.chemrev.6b00351","volume":"116","author":"BM Dancy","year":"2016","unstructured":"Dancy, B. M. & Cole, P. A. Correction to protein lysine acetylation by p300\/CBP. Chem. Rev. 116, 8314 (2016).","journal-title":"Chem. Rev."},{"key":"1338_CR20","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s12276-021-00556-4","volume":"53","author":"SM Son","year":"2021","unstructured":"Son, S. M., Park, S. J., Fernandez-Estevez, M. & Rubinsztein, D. C. Autophagy regulation by acetylation\u2014implications for neurodegenerative diseases. Exp. Mol. Med. 53, 30\u201341 (2021).","journal-title":"Exp. Mol. Med."},{"key":"1338_CR21","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cell.2018.04.033","volume":"174","author":"BT Weinert","year":"2018","unstructured":"Weinert, B. T. et al. Time-resolved analysis reveals rapid dynamics and broad scope of the CBP\/p300 acetylome. Cell 174, 231\u2013244 e212 (2018).","journal-title":"Cell"},{"key":"1338_CR22","doi-asserted-by":"publisher","first-page":"e11058","DOI":"10.7554\/eLife.11058","volume":"5","author":"B Carroll","year":"2016","unstructured":"Carroll, B. et al. Control of TSC2\u2013Rheb signaling axis by arginine regulates mTORC1 activity. eLife 5, e11058 (2016).","journal-title":"eLife"},{"key":"1338_CR23","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","volume":"110","author":"A Fleming","year":"2022","unstructured":"Fleming, A. et al. The different autophagy degradation pathways and neurodegeneration. Neuron 110, 935\u2013966 (2022).","journal-title":"Neuron"},{"key":"1338_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","volume":"17","author":"DJ Klionsky","year":"2021","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy 17, 1\u2013382 (2021).","journal-title":"Autophagy"},{"key":"1338_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.molcel.2014.01.016","volume":"53","author":"G Marino","year":"2014","unstructured":"Marino, G. et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Mol. Cell 53, 710\u2013725 (2014).","journal-title":"Mol. Cell"},{"key":"1338_CR26","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.1074\/jbc.M807135200","volume":"284","author":"IH Lee","year":"2009","unstructured":"Lee, I. H. & Finkel, T. Regulation of autophagy by the p300 acetyltransferase. J. Biol. Chem. 284, 6322\u20136328 (2009).","journal-title":"J. Biol. Chem."},{"key":"1338_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31905-0","volume":"13","author":"L Wrobel","year":"2022","unstructured":"Wrobel, L. et al. Compounds activating VCP D1 ATPase enhance both autophagic and proteasomal neurotoxic protein clearance. Nat. Commun. 13, 4146 (2022).","journal-title":"Nat. Commun."},{"key":"1338_CR28","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.cell.2020.04.025","volume":"181","author":"H Katayama","year":"2020","unstructured":"Katayama, H. et al. Visualizing and modulating mitophagy for therapeutic studies of neurodegeneration. Cell 181, 1176\u20131187 e1116 (2020).","journal-title":"Cell"},{"key":"1338_CR29","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3390\/cancers13061288","volume":"13","author":"KKY Lai","year":"2021","unstructured":"Lai, K. K. Y. et al. p300 serine 89: a critical signaling integrator and its effects on intestinal homeostasis and repair. Cancers 13, 1288 (2021).","journal-title":"Cancers"},{"key":"1338_CR30","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1002\/hep.30668","volume":"70","author":"YG Wang","year":"2019","unstructured":"Wang, Y. G. et al. p300 acetyltransferase is a cytoplasm-to-nucleus shuttle for SMAD2\/3 and TAZ nuclear transport in transforming growth factor beta-stimulated hepatic stellate cells. Hepatology 70, 1409\u20131423 (2019).","journal-title":"Hepatology"},{"key":"1338_CR31","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2017.09.020","volume":"68","author":"W Wan","year":"2017","unstructured":"Wan, W. et al. mTORC1 phosphorylates acetyltransferase p300 to regulate autophagy and lipogenesis. Mol. Cell 68, 323\u2013335 e326 (2017).","journal-title":"Mol. Cell"},{"key":"1338_CR32","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4161\/auto.4451","volume":"3","author":"S Kimura","year":"2007","unstructured":"Kimura, S., Noda, T. & Yoshimori, T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 3, 452\u2013460 (2007).","journal-title":"Autophagy"},{"key":"1338_CR33","doi-asserted-by":"publisher","first-page":"e141344","DOI":"10.1172\/jci.insight.141344","volume":"7","author":"VF Martins","year":"2022","unstructured":"Martins, V. F. et al. p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. JCI Insight 7, e141344 (2022).","journal-title":"JCI Insight"},{"key":"1338_CR34","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1073\/pnas.1313618111","volume":"111","author":"S Sebti","year":"2014","unstructured":"Sebti, S. et al. BAT3 modulates p300-dependent acetylation of p53 and autophagy-related protein 7 (ATG7) during autophagy. Proc. Natl Acad. Sci. USA 111, 4115\u20134120 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1338_CR35","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1359\/jbmr.2003.18.8.1419","volume":"18","author":"T Iioka","year":"2003","unstructured":"Iioka, T. et al. P300\/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain. J. Bone Miner. Res. 18, 1419\u20131429 (2003).","journal-title":"J. Bone Miner. Res."},{"key":"1338_CR36","doi-asserted-by":"publisher","first-page":"6592","DOI":"10.1128\/MCB.25.15.6592-6602.2005","volume":"25","author":"WC Huang","year":"2005","unstructured":"Huang, W. C. & Chen, C. C. Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity. Mol. Cell. Biol. 25, 6592\u20136602 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"1338_CR37","doi-asserted-by":"publisher","first-page":"40946","DOI":"10.1074\/jbc.M007832200","volume":"275","author":"LW Yuan","year":"2000","unstructured":"Yuan, L. W. & Gambee, J. E. Phosphorylation of p300 at serine 89 by protein kinase C. J. Biol. Chem. 275, 40946\u201340951 (2000).","journal-title":"J. Biol. Chem."},{"key":"1338_CR38","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/nar\/gks1312","volume":"41","author":"QE Wang","year":"2013","unstructured":"Wang, Q. E. et al. p38 MAPK- and Akt-mediated p300 phosphorylation regulates its degradation to facilitate nucleotide excision repair. Nucleic Acids Res. 41, 1722\u20131733 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1338_CR39","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1161\/ATVBAHA.111.237453","volume":"31","author":"Y Zhang","year":"2011","unstructured":"Zhang, Y., Qiu, J., Wang, X., Zhang, Y. & Xia, M. AMP-activated protein kinase suppresses endothelial cell inflammation through phosphorylation of transcriptional coactivator p300. Arterioscler. Thromb. Vasc. Biol. 31, 2897\u20132908 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1338_CR40","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.devcel.2021.05.010","volume":"56","author":"C Karabiyik","year":"2021","unstructured":"Karabiyik, C., Vicinanza, M., Son, S. M. & Rubinsztein, D. C. Glucose starvation induces autophagy via ULK1-mediated activation of PIKfyve in an AMPK-dependent manner. Dev. Cell 56, 1961\u20131975 e1965 (2021).","journal-title":"Dev. Cell"},{"key":"1338_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41420-020-0260-9","volume":"6","author":"G Leprivier","year":"2020","unstructured":"Leprivier, G. & Rotblat, B. How does mTOR sense glucose starvation? AMPK is the usual suspect. Cell Death Discov. 6, 27 (2020).","journal-title":"Cell Death Discov."},{"key":"1338_CR42","doi-asserted-by":"publisher","first-page":"38625","DOI":"10.1074\/jbc.M112.365767","volume":"287","author":"G Ghislat","year":"2012","unstructured":"Ghislat, G., Patron, M., Rizzuto, R. & Knecht, E. Withdrawal of essential amino acids increases autophagy by a pathway involving Ca2+\/calmodulin-dependent kinase kinase-beta (CaMKK-beta). J. Biol. Chem. 287, 38625\u201338636 (2012).","journal-title":"J. Biol. Chem."},{"key":"1338_CR43","doi-asserted-by":"publisher","first-page":"15813","DOI":"10.1074\/jbc.M201075200","volume":"277","author":"H Tokumitsu","year":"2002","unstructured":"Tokumitsu, H. et al. STO-609, a specific inhibitor of the Ca(2+)\/calmodulin-dependent protein kinase kinase. J. Biol. Chem. 277, 15813\u201315818 (2002).","journal-title":"J. Biol. Chem."},{"key":"1338_CR44","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/S1097-2765(01)00251-9","volume":"7","author":"J Mu","year":"2001","unstructured":"Mu, J., Brozinick, J. T. Jr, Valladares, O., Bucan, M. & Birnbaum, M. J. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol. Cell 7, 1085\u20131094 (2001).","journal-title":"Mol. Cell"},{"key":"1338_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1042\/BJ20091834","volume":"427","author":"C Johnson","year":"2010","unstructured":"Johnson, C. et al. Bioinformatic and experimental survey of 14-3-3-binding sites. Biochem. J. 427, 69\u201378 (2010).","journal-title":"Biochem. J."},{"key":"1338_CR46","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1128\/MCB.25.2.525-532.2005","volume":"25","author":"J Chen","year":"2005","unstructured":"Chen, J., St-Germain, J. R. & Li, Q. B56 regulatory subunit of protein phosphatase 2A mediates valproic acid-induced p300 degradation. Mol. Cell. Biol. 25, 525\u2013532 (2005).","journal-title":"Mol. Cell. Biol."},{"key":"1338_CR47","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/j.1349-7006.2010.01523.x","volume":"101","author":"W Li","year":"2010","unstructured":"Li, W. et al. Cantharidin, a potent and selective PP2A inhibitor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2\/M cell-cycle arrest and apoptosis. Cancer Sci. 101, 1226\u20131233 (2010).","journal-title":"Cancer Sci."},{"key":"1338_CR48","doi-asserted-by":"publisher","first-page":"e11466","DOI":"10.7554\/eLife.11466","volume":"4","author":"K Kirli","year":"2015","unstructured":"Kirli, K. et al. A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. eLife 4, e11466 (2015).","journal-title":"eLife"},{"key":"1338_CR49","doi-asserted-by":"publisher","first-page":"eaar5401","DOI":"10.1126\/scisignal.aar5401","volume":"11","author":"D Larrieu","year":"2018","unstructured":"Larrieu, D. et al. Inhibition of the acetyltransferase NAT10 normalizes progeric and aging cells by rebalancing the Transportin-1 nuclear import pathway. Sci. Signal 11, eaar5401 (2018).","journal-title":"Sci. Signal"},{"key":"1338_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ymeth.2015.08.024","volume":"96","author":"N Kubben","year":"2016","unstructured":"Kubben, N., Brimacombe, K. R., Donegan, M., Li, Z. & Misteli, T. A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds. Methods 96, 46\u201358 (2016).","journal-title":"Methods"},{"key":"1338_CR51","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.neuron.2018.07.039","volume":"99","author":"B Eftekharzadeh","year":"2018","unstructured":"Eftekharzadeh, B. et al. Tau protein disrupts nucleocytoplasmic transport in Alzheimer\u2019s disease. Neuron 99, 925\u2013940 e927 (2018).","journal-title":"Neuron"},{"key":"1338_CR52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuron.2017.03.023","volume":"94","author":"JC Grima","year":"2017","unstructured":"Grima, J. C. et al. Mutant huntingtin disrupts the nuclear pore complex. Neuron 94, 93\u2013107 e106 (2017).","journal-title":"Neuron"},{"key":"1338_CR53","doi-asserted-by":"publisher","first-page":"e13002","DOI":"10.1111\/acel.13002","volume":"18","author":"I Garcia-Aguirre","year":"2019","unstructured":"Garcia-Aguirre, I. et al. Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity. Aging Cell 18, e13002 (2019).","journal-title":"Aging Cell"},{"key":"1338_CR54","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/acel.12434","volume":"15","author":"ZM Xiong","year":"2016","unstructured":"Xiong, Z. M. et al. Methylene blue alleviates nuclear and mitochondrial abnormalities in progeria. Aging Cell 15, 279\u2013290 (2016).","journal-title":"Aging Cell"},{"key":"1338_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1126\/science.aad2087","volume":"351","author":"RA Saxton","year":"2016","unstructured":"Saxton, R. A. et al. Structural basis for leucine sensing by the Sestrin2\u2013mTORC1 pathway. Science 351, 53\u201358 (2016).","journal-title":"Science"},{"key":"1338_CR56","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214\u2013226 (2008).","journal-title":"Mol. Cell"},{"key":"1338_CR57","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1016\/j.molcel.2023.07.011","volume":"83","author":"C Xu","year":"2023","unstructured":"Xu, C. et al. O-GlcNAcylation of raptor transduces glucose signals to mTORC1. Mol. Cell 83, 3027\u20133040 e3011 (2023).","journal-title":"Mol. Cell"},{"key":"1338_CR58","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas, J. et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev. 18, 2893\u20132904 (2004).","journal-title":"Genes Dev."},{"key":"1338_CR59","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1158\/0008-5472.CAN-06-4149","volume":"67","author":"Z Feng","year":"2007","unstructured":"Feng, Z. et al. The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1\u2013AKT\u2013mTOR pathways. Cancer Res. 67, 3043\u20133053 (2007).","journal-title":"Cancer Res."},{"key":"1338_CR60","doi-asserted-by":"publisher","first-page":"e0168988","DOI":"10.1371\/journal.pone.0168988","volume":"11","author":"D Gabriel","year":"2016","unstructured":"Gabriel, D., Gordon, L. B. & Djabali, K. Temsirolimus partially rescues the Hutchinson\u2013Gilford progeria cellular phenotype. PLoS ONE 11, e0168988 (2016).","journal-title":"PLoS ONE"},{"key":"1338_CR61","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.cmet.2017.09.024","volume":"26","author":"HJ Weir","year":"2017","unstructured":"Weir, H. J. et al. Dietary restriction and AMPK increase lifespan via mitochondrial network and peroxisome remodeling. Cell Metab. 26, 884\u2013896 e885 (2017).","journal-title":"Cell Metab."},{"key":"1338_CR62","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.arr.2011.12.005","volume":"11","author":"A Salminen","year":"2012","unstructured":"Salminen, A. & Kaarniranta, K. AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res. Rev. 11, 230\u2013241 (2012).","journal-title":"Ageing Res. Rev."},{"key":"1338_CR63","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/exd.13323","volume":"26","author":"SK Park","year":"2017","unstructured":"Park, S. K. & Shin, O. S. Metformin alleviates ageing cellular phenotypes in Hutchinson\u2013Gilford progeria syndrome dermal fibroblasts. Exp. Dermatol. 26, 889\u2013895 (2017).","journal-title":"Exp. Dermatol."},{"key":"1338_CR64","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.mehy.2018.06.029","volume":"118","author":"J Finley","year":"2018","unstructured":"Finley, J. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson\u2013Gilford progeria syndrome. Med. Hypotheses 118, 151\u2013162 (2018).","journal-title":"Med. Hypotheses"},{"key":"1338_CR65","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ng871","volume":"31","author":"AM Pendas","year":"2002","unstructured":"Pendas, A. M. et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat. Genet. 31, 94\u201399 (2002).","journal-title":"Nat. Genet."},{"key":"1338_CR66","doi-asserted-by":"publisher","first-page":"12325","DOI":"10.1073\/pnas.1102789108","volume":"108","author":"V Krishnan","year":"2011","unstructured":"Krishnan, V. et al. Histone H4 lysine 16 hypoacetylation is associated with defective DNA repair and premature senescence in Zmpste24-deficient mice. Proc. Natl Acad. Sci. USA 108, 12325\u201312330 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1338_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-01766-5","volume":"7","author":"E Metzakopian","year":"2017","unstructured":"Metzakopian, E. et al. Enhancing the genome editing toolbox: genome wide CRISPR arrayed libraries. Sci. Rep. 7, 2244 (2017).","journal-title":"Sci. Rep."},{"key":"1338_CR68","doi-asserted-by":"publisher","first-page":"14349","DOI":"10.1523\/JNEUROSCI.2969-07.2007","volume":"27","author":"U Narayanan","year":"2007","unstructured":"Narayanan, U. et al. FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J. Neurosci. 27, 14349\u201314357 (2007).","journal-title":"J. Neurosci."}],"updated-by":[{"DOI":"10.1038\/s41556-025-01850-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000}},{"DOI":"10.1038\/s41556-026-02120-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000}}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-023-01338-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-023-01338-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-023-01338-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:02:13Z","timestamp":1791874933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-023-01338-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,24]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1038\/s41556-023-01338-y","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,24]]},"assertion":[{"value":"12 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41556-026-02120-6","URL":"https:\/\/doi.org\/10.1038\/s41556-026-02120-6","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41556-025-01850-3","URL":"https:\/\/doi.org\/10.1038\/s41556-025-01850-3","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.C.R. is a consultant for Aladdin Healthcare Technologies Ltd, Mindrank AI, Nido Biosciences, Drishti Discoveries, Retro Biosciences Inc. and PAQ Therapeutics. D.L. is a cofounder of Adrestia Therapeutics and a scientific advisor for Shift Bioscience and Adrestia Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}